Efficacy of 5-fluorouracil (5-FU) and low molecular weight heparin (LMWH) in high-risk pediatric retinal detachment; randomized clinical trial

被引:0
|
作者
Mohamed Nasr
Ahmed Abdelhadi
Amr Bessa
Tamer Moussa Ibrahim
机构
[1] Alexandria University,Department of Ophthalmology, Faculty of Medicine
来源
关键词
Pediatric retinal detachment; Proliferative vitreoretinopathy; 5-fluorouracil; Low molecular weight heparin; Recurrent retinal detachment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Efficacy of 5-fluorouracil (5-FU) and low molecular weight heparin (LMWH) in high-risk pediatric retinal detachment; randomized clinical trial
    Nasr, Mohamed
    Abdelhadi, Ahmed
    Bessa, Amr
    Ibrahim, Tamer Moussa
    BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [2] 5-FLUOROURACIL(5-FU) IN PRIMARY TRABECULECTOMY - A RANDOMIZED TRIAL
    LOFTFIELD, K
    BALL, SF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 745 - 745
  • [3] CLINICAL EFFICACY OF LOW DOSE INTRALESIONAL 5-FLUOROURACIL (5-FU) IN THE TREATMENT OF KELOIDS
    Shivaswamy, K. N.
    Shyamprasad, A. L.
    Sumathy, T. K.
    Suparna, M. Y.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (97): : 16229 - 16231
  • [4] Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial
    Friederike Schaub
    Robert Hoerster
    Petra Schiller
    Moritz Felsch
    Daria Kraus
    Marouan Zarrouk
    Bernd Kirchhof
    Sascha Fauser
    Trials, 19
  • [5] Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial
    Schaub, Friederike
    Hoerster, Robert
    Schiller, Petra
    Felsch, Moritz
    Kraus, Daria
    Zarrouk, Marouan
    Kirchhof, Bernd
    Fauser, Sascha
    TRIALS, 2018, 19
  • [6] Effect of intraoperative 5-fluorouracil and low molecular weight heparin on the outcome of high-risk proliferative vitreoretinopathy
    Ganekal, Sunil
    Dorairaj, Syril
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2014, 28 (04) : 257 - 261
  • [7] Clinical efficacy of 5-fluorouracil (5-FU) topical cream for treatment of cholesteatoma
    Takahashi, H
    Funabiki, K
    Hasebe, S
    Fukuda-Yamamoto, T
    Kaieda, S
    Iwanaga, T
    Kumagami, H
    Takasaki, K
    AURIS NASUS LARYNX, 2005, 32 (04) : 353 - 357
  • [8] Pars Plana Vitrectomy with adjunctive 5-fluorouracil and low-molecular weight heparin for complicated retinal detachment
    Acar, N
    Kapran, Z
    Unver, YB
    Karakaya, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [9] RADIOSENSITIZATION BY 5-FLUOROURACIL (5-FU) - MOLECULAR ORIGINS AND CLINICAL SCHEDULING IMPLICATIONS
    BYFIELD, JE
    CHAN, PYM
    SEAGREN, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 74 - 74
  • [10] CLINICAL AND COMPATIBILITY STUDIES OF 5-FLUOROURACIL (5-FU) AND HEPARIN (HN) ADMINISTERED BY CONTINUOUS IV INFUSION
    COUGHENOUR, M
    SLAVIK, M
    FABIAN, C
    BROWN, N
    CHENG, CC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 191 - 191